Close Menu

NEW YORK (360Dx) – Gold Standard Diagnostics said today that the US Food and Drug Administration has cleared the company's Borrelia burgdorferi IgG/IgM ELISA assay.

The test is intended for use as the initial screen in the two-step testing process recommended by the US Centers for Disease Control and Prevention for detecting antibodies against B. burgdorferi, a bacterial species that can cause Lyme disease. GSD said that both steps can be performed using the same blood sample.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.